April 09, 2026 11:21 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jaishankar’s high-stakes diplomatic tour: EAM to visit UAE this week, first visit amid Middle East conflict | Passport row: Barricades outside Pawan Khera’s Hyderabad house after Himanta Biswa Sarma's warning | ‘Allow excluded voters to vote’: Mamata slams voter list freeze amid SIR row, to move Supreme Court | US, Iran agree to 2-week ceasefire deal, reopening Strait of Hormuz | ‘Prudent to wait and watch’: RBI keeps repo rate unchanged at 5.25% amid global volatility | 91 lakh voters dropped from rolls in Bengal SIR; Muslim-majority Murshidabad tops deletion list | Air India CEO Campbell Wilson quits amid losses, regulatory heat after deadly Ahmedabad crash: Report | Could be taken out in one night: Donald Trump’s chilling warning to Iran as deadline approaches | IRGC Intelligence Chief Majid Khademi killed in Israeli-US strike | Setback for Arunachal CM Pema Khandu as SC orders CBI probe into public works contracts

GlaxoSmithKline records 8% growth

| | Aug 07, 2014, at 04:03 am
New Delhi, Aug 6 (IBNS): GlaxoSmithKline Consumer Healthcare Limited on Wednesday declared its financial results for the first quarter ended June 30, 2014, where it recorded its net sales at Rs 922 crores, making a growth of 8% over 2013 with PAT at Rs. 130 crores growing by 9% for the same period and PBT at Rs 198 crores growing by 9%.
Commenting on the results, Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “We are proud to deliver consistent growth ahead of the category. This is significant in a scenario where consumption pattern is being impacted by inflation. Our sciences based products with its superior value, continue to remain relevant for our large consumer base."
 
"As a market leader we are also growing the category with successful launches of new products which are driving up consumption experiences. Our focused access strategy ensures that consumption and penetration has been the enabler for growth. Customer driven innovations and clutter breaking marketing based on sharp consumer insights will continue to be our driving force in the coming months to bring in more consumers closer to the product," he said.
 
The company also noted that in a recent addition to the Board of Directors, Sangeeta Talwar has been appointed as an Independent Director in casual vacancy created by the resignation of Ireena Vittal. 
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm